Trials / Completed
CompletedNCT01540799
Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Autonomic Technologies, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the clinical study is to evaluate the use of an implanted sphenopalatine ganglion (SPG) neurostimulator for the treatment of migraine headache pain, migraine headache symptoms and migraine frequency in high disability migraineurs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ATI Neurostimulation System | ATI Neurostimulator (NS-100) and Remote Controller (RC-200) |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2018-05-01
- Completion
- 2018-05-01
- First posted
- 2012-02-29
- Last updated
- 2018-06-26
Locations
3 sites across 3 countries: Belgium, Denmark, Spain
Source: ClinicalTrials.gov record NCT01540799. Inclusion in this directory is not an endorsement.